Los Angeles County
Department of Public Health
Tuberculosis Control Program
2615 S. Grand Avenue, Room 507
Los Angeles, CA 90007
Phone: (213) 744-6160
Fax: (213) 749-0926
Email: tb@ph.lacounty.gov

Guidelines

International:

• International Standards for Tuberculosis Care Lancet Infect Dis 2006; 6:710-715
• WHO TB Air Travel Guidelines

CDC:

• Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
• Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 MMWR 54(RR15);1-37
• Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 MMWR Vol. 54 / RR17;1-141.
• MMWR: Errata: Treatment of Tuberculosis MMWR 2005; 52, (RR-11)
• Guidelines for Using the QuantiFERON®-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States MMWR Recommendations and Reports, December 16, 2005 / Vol. 54 / No. RR-15
• TB/HIV Drug Interactions, 2004, Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
• Treatment of Tuberculosis American Thoracic Society, CDC, and Infectious Diseases Society of America MMWR Recommendations and Reports 2003: 52, (RR11);1-77
• Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003 MMWR 2003; 52 (No. 31)
• Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection MMWR Weekly 2002, Vol. 51 / No. 44, pages 998 - 999
• Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations --- United States, 2001 MMWR Weekly, Vol. 50 / No. 34, pages 733-735
• Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR Recommendations and Reports 2000, Vol. 49 / No. RR-06
• Diagnostic Standards and Classification of Tuberculosis in Adults and Children , Am J Respir Crit Care Med Vol 161. pp 1376–1395, 2000
• Notice to Reader: Update: Nucleic Acid Amplication Test for Tuberculosis, MMWR 2000, Vol 49, pages 593-594
• Notice to Readers: Acquired Rifamycin Resistance in Persons with Advanced HIV Disease Being Treated for Active Tuberculosis with Intermittent Rifamycin-Based Regimens MMWR Weekly, Vol. 51 / No. 10, pages 214-215
• Prevention and Treatment of Tuberculosis Among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations MMWR Recommendations and Reports, Vol. 47 / No. RR-20
• Public Health Service Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis MMWR Recommendations and Reports, Vol. 47 / RR-07
• Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations MMWR Recommendations and Reports, Vol. 46 / No. RR-15 1-10
• Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Aniretroviral Agents in HIV-Infected Adults and Adolescents HIV/AIDS Treatment Information Service (ATIS) report, 121 pages
• Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin MMWR Weekly, Vol. 45 / No. 42, pages 921-925
• Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis, Recommendations from the National Tuberculosis Controllers Association and CDC MMWR Recommendations and Reports, Vol. 54(RR15);1-37
• Exposure of Passengers and Flight Crew to Mycobacterium tuberculosis on Commercial Aircraft, 1992-1995 MMWR Weekly, Vol. 44 / No. 8, pages 137-140

U.S. Department of Health and Human Services:

• Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents - January 29, 2008
• Drug Interactions Among Antiretrovirals and Other Drugs: PIs and Maraviroc
• Drug Interactions Among Antiretrovirals and Other Drugs: NNRTIs

State of California:

• California Department of Health Services and California Tuberculosis Controllers Association CDHS/CTCA Joint Guidelines

L.A. County:

• Directly Observed Therapy (DOT)
• Summary of Important TB Treatment Guidelines
• Treatment Guidelines
• Treatment of Tuberculosis
• Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection